Patent details

EP4098256 Title: DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP4098256
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP22187007.4
WO Publication Number:
EPO Publication Language:
English
SPC Number:
301324
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
21/12/2009
Grant date:
26/02/2025
EP Publication Date:
07/12/2022
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
26/03/2025
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
26/02/2025
EP B1 Publication Date:
26/02/2025
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
20/12/2029
Lapsed By Expiration Date:
Patent Validated Date:
09/04/2025
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
26/02/2025
 
 

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Agent

Name:
dr. R.C. van Duijvenbode c.s.
From:
07/04/2025
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
SCHMOUDER, Robert
Address:
East Hanover, United States of America (US)

2

Name:
DUMORTIER, Thomas
Address:
Basel, Switzerland (CH)

3

Name:
DAVID, Olivier
Address:
Basel, Switzerland (CH)

4

Name:
LOOBY, Michael
Address:
Basel, Switzerland (CH)

Priority

1

Priority Patent Number:
246715 P
Priority Date:
29/09/2009
Priority Country:
United States of America (US)

2

Priority Patent Number:
218530 P
Priority Date:
19/06/2009
Priority Country:
United States of America (US)

3

Priority Patent Number:
139672 P
Priority Date:
22/12/2008
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/137; A61P 37/00; A61P 37/06; A61K 31/135; A61K 31/138; A61K 31/661;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
15/25
Publication date:
09/04/2025
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
09/25
Publication date:
26/02/2025
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202509
Publication date:
26/02/2025
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
31/12/2025
Annual Fee Number:
17
Annual Fee Amount:
1100 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
08/04/2025 Outgoing Correspondence Letter no formal defects 1 PDF /5/9/7/0/9/0801090795/docs/ep22187007.4_1_651363l271.pdf
26/03/2025 Claims First filed claims 1 PDF /5/9/7/0/9/0801090795/docs/ep22187007.4_0_claims20250326074510149.pdf